Privacy & Cookies Policy

This website uses cookies to improve your experience. You can opt-out if you wish. Read More

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Customer Login

NEW PUBLICATION

TwinStrand DuplexSeq measuring MRD in AML

View Paper

NITROSAMINE MUTAGENICITY TESTING

Duplex Sequencing offers a solution for those in need of in vivo mutagenicity data

DOWNLOAD APP NOTE

TwinStrand DuplexSeqTM for assessing nitrosamine impurities

Don’t wait for your in vivo mutagenicity data

Duplex Sequencing studies provide the Mutation Frequency (MF) data you need for mutagenicity testing and BMD modeling without having to wait for a TGR study.

  • Compatible with both wild-type and transgenic rodents
  • Repurpose tissues from general tox studies to assess mutagenicity
  • Gain additional data on mutation type to supplement mutation frequency

Resources

Duplex Sequencing has been successfully applied to nitrosamine testing. The Bercu et al. paper provides an excellent template for nitrosamine studies using ecNGS. The HESI position paper offers expert perspective on applications for ecNGS in nonclinical genotoxicity testing. More publications featuring nitrosamine and bridging studies can be found on the publications page.

View Publications

NITROSAMINE (NDEA) PUBLICATION ​

Comparative dose-response study assessing the detection of N-nitrosamine (NDEA) exposure using ecNGS (Duplex Sequencing) and the TGR Assay​

HESI position publication

A position paper on genetic toxicology applications for ecNGS written by members of the HESI Genetic Toxicology Technical Committee (GTTC) – an interdisciplinary group of genetox experts from industry, academia, and government ​

For Research Use Only. Not for use in diagnostic procedures.

©2024 TwinStrand Biosciences, Inc. All rights reserved. All trademarks are the property of TwinStrand Biosciences, Inc. or their respective owners. Legal Notices

Stay up to date